Skip to main content
Skip to section navigation
Skip to footer
Home
About
Overview
Management Team
Board of Directors
Advisory Board
Pipeline
Overview
XRx-008 for Autosomal Dominant Polycystic Kidney Disease
XRx-101 for Coronavirus/COVID-19
XRX-225 for Type 2 Diabetic Nephropathy
Publications
Technology
News & Media
Press Releases
Events
In the News
Investors
Overview
News & Events
Presentations
Company Info
Financial Info
Stock Data
SEC Filings
SEDAR+
Governance
Contact
All SEC Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Presentations
Company Info
Overview
Management Team
Contacts
FAQ
Financial Info
Financial Results
Stock Data
Analyst Coverage
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
SEDAR+
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Board Diversity Matrix
Filing Type:
View All
20-F
20-F/A
424B3
424B4
424B5
6-K
6-K/A
8-A12B
8-A12B/A
CERT
CORRESP
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-3
NT 20-F
POS AM
S-8
SC 13G
SC 13G/A
SEC STAFF LETTER
UPLOAD
Year:
View All
2024
2023
2022
2021
2018
Date
Form
Description
PDF
XBRL
Pages
04/30/24
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
expand_more
EX-99.1
4
04/22/24
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
expand_more
EX-99.1
5
04/08/24
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
expand_more
EX-99.1
4
04/08/24
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
expand_more
EX-99.1
4
04/04/24
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
expand_more
EX-99.1
EX-99.2
EX-99.3
EX-99.4
EX-99.5
84
03/27/24
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
expand_more
EX-99.1
4
03/20/24
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
expand_more
EX-99.1
5
02/14/24
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
7
01/03/24
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
expand_more
EX-99.1
5
01/02/24
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
expand_more
EX-99.1
4
rss_feed
Filing RSS
arrow_back
1
2
3
4
5
6
7
8
9
10
…20
arrow_forward
Email Alerts
Contacts
RSS News Feed